These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32381473)

  • 1. The importance of antiphospholipid syndrome testing in venous thromboembolism after varicose vein surgery.
    Wahl U; Hirsch T
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1097-1101. PubMed ID: 32381473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent venous thromboembolism after discontinuation of rivaroxaban therapy in a patient with antiphospholipid syndrome.
    Yagi S; Nishiyama S; Abe T; Sata M
    BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30635311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiphospholipid triangle.
    Galli M
    J Thromb Haemost; 2010 Feb; 8(2):234-6. PubMed ID: 19912514
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of Direct Oral Anticoagulants in Patients with Sickle Cell Disease and Venous Thromboembolism: A Prospective Cohort Study of 12 Patients.
    Christen JR; Bertolino J; Jean E; Camoin L; Ebbo M; Harlé JR; Schleinitz N; Sarlon G; Bernit E
    Hemoglobin; 2019; 43(4-5):296-299. PubMed ID: 31724442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibodies in critical illness.
    Dentali F; Crowther M
    Crit Care Med; 2010 Feb; 38(2 Suppl):S51-6. PubMed ID: 20083914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trial of antithrombotic therapy in patients with refractory migraine and antiphospholipid antibodies: A retrospective study of 75 patients.
    Schofield JR; Hughes HN; Birlea M; Hassell KL
    Lupus; 2021 Apr; 30(4):568-577. PubMed ID: 33402037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study.
    Hendriks T; McGregor S; Rakesh S; Robinson J; Ho KM; Baker R
    PLoS One; 2020; 15(6):e0234048. PubMed ID: 32497116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Venous thromboembolism and antiphospholipid syndrome - considerations on diagnosis and treatment].
    van Mens TE; Middeldorp S; Coppens M
    Ned Tijdschr Geneeskd; 2023 Mar; 167():. PubMed ID: 36928879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibiodies: a critical review of the literature.
    Lim W; Crowther MA
    Curr Opin Hematol; 2007 Sep; 14(5):494-9. PubMed ID: 17934356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of venous thromboembolism in patients undergoing surgical treatment of varicose veins.
    Testroote MJ; Wittens CH
    Phlebology; 2013 Mar; 28 Suppl 1():86-90. PubMed ID: 23482541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data.
    Kushnir M; Choi Y; Eisenberg R; Rao D; Tolu S; Gao J; Mowrey W; Billett HH
    Lancet Haematol; 2019 Jul; 6(7):e359-e365. PubMed ID: 31133411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in patients with nontriple antiphospholipid syndrome (APS) anticoagulated with rivaroxaban.
    Htut TW; Milne D; Khan MM; Watson HG
    Int J Lab Hematol; 2021 Oct; 43(5):e252-e253. PubMed ID: 33470532
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial.
    Pengo V; Banzato A; Bison E; Zoppellaro G; Padayattil Jose S; Denas G
    Lupus; 2016 Mar; 25(3):301-6. PubMed ID: 26466613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of factor Xa inhibitors in venous thromboembolism treatment.
    Cabral KP; Ansell JE
    Vasc Health Risk Manag; 2015; 11():117-23. PubMed ID: 25673997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral Venous Thromboembolism in Antiphospholipid Syndrome Successfully Treated with the Combined Use of an Anti-Xa Inhibitor and Corticosteroid.
    Sugie M; Iizuka N; Shimizu Y; Ichikawa H
    Intern Med; 2015; 54(23):3051-6. PubMed ID: 26631891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bilateral adrenal hemorrhage under apixaban in primary antiphospholipid syndrome].
    Lavoipierre V; Talbot M; Soubrier C; De Sainte Marie B; Seux V; Solas C; Morange P; Bernit E; Ebbo M; Faucher B; Harlé JR; Schleinitz N
    Rev Med Interne; 2020 Jul; 41(7):489-492. PubMed ID: 31672255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibodies.
    Houghton DE; Moll S
    Vasc Med; 2017 Dec; 22(6):545-550. PubMed ID: 29103369
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of Xa inhibitors for the treatment of cancer-associated venous thromboembolism.
    Kimpton M; Carrier M
    Expert Opin Drug Saf; 2019 Apr; 18(4):313-320. PubMed ID: 30925842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibodies and thrombosis.
    Musiał J
    Thromb Res; 2012 Mar; 129(3):345-7. PubMed ID: 22119156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.
    Ma G; Zhang R; Wu X; Wang D; Ying K
    Thromb Res; 2015 May; 135(5):816-22. PubMed ID: 25728496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.